JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (4): 64-67.doi: 10.6040/j.issn.1673-3770.0.2016.494

Previous Articles     Next Articles

RASSF2A methylation in laryngeal squamous cell carcinoma.

ZHANG Mingde1, ZHANG Zuping2, YU Xuemin3, WEI Yanhong1, YUAN Ying3   

  1. 1. Department of Otolaryngology, Liaocheng Dongchangfu Peoples Hospital, Liaocheng 252000, Shangdong, China;2. Department of Otolaryngology, Liaocheng Peoples Hospital, Liaocheng 252000, Shangdong, China;3. Department of Otolaryngology &Head and Neck Surgery, Qilu Hospital of Shandong University, Qingdao 266035, Shandong, China
  • Received:2016-11-23 Online:2017-08-16 Published:2017-08-16

PDF (PC)

267

Abstract: Objective To evaluate the effects of methylation on RASSF2A expression during the development of laryngeal squamous cell carcinoma(LSCC). Methods Methylation-specific PCR was used to measure RASSF2A methylation and mRNA levels in tissues from 50 LSCCs(LSCC group)and 10 normal laryngeal tissues(control group). Results Hypermethylation was detected in the promoter region of RASSF2A in 54%(27/50)of the laryngeal cancer tissue samples but was not detected in control group tissues. The difference in hypermethylation was statistically significant(χ2=9.818, P=0.002). No significant correlations were found between the methylation levels of RASSF2A and the clinicopathological features of the patients with laryngeal cancer. The levels of RASSF2A mRNA in the LSCC group were significantly lower than those in normal mucosal tissues(χ2=9.818, P=0.002), because of methylation in RASSF2A in the laryngeal cancer tissue samples. Conclusion Epigenetic inactivation of RASSF2A through aberrant promoter methylation may play an important role during oncogenesis and the progression of LSCC.

Key words: Methylation, RASSF2A, Laryngeal squamous cell carcinoma

CLC Number: 

  • R739.65
[1] Karatzanis AD, Psychogios G, Waldfahrer F, et al. Management of locally advanced laryngeal cancer[J]. J Otolaryngol Head Neck Surg, 2014, 43(1):4.
[2] Gurbuz MK, Acikalin M, Tasar S, et al. Clinical effectiveness of thyroidectomy on the management of locally advanced laryngeal cancer[J]. Auris Nasus Larynx, 2014, 41(1):69-75.
[3] 李万举,孙敬武,别远志. Ras相关区域家族1A基因在喉癌及喉角化症组织中的表达及临床意义[J]. 听力学及言语疾病杂志,2014,22(6):616-619. LI Wanju, SUN Jingwu, BIE Yuanzhi. ImmunohistochemicaI expression and cIinicaI impIication of RASSF1A gene in laryngeaI squamous ceII carcinoma and keratosis of the larynx[J]. Journal of Audiology and Speech Pathology, 2014, 22(6):616-619.
[4] 许承弼,腾博,李长青,等. 喉鳞状细胞癌中RASSF1A基因启动子区甲基化及蛋白表达[J].吉林大学学报(医学版),2006,32(2):326-329. XU Chengbi, TENG Bo, LI Changqing, et al. Promoter methylation of RASSF1A gene in laryngeal squamous cell carcinoma and protein expression[J]. J Jilin Univ(Med Edition), 2006, 32(2):326-329.
[5] Wu Y, Zhang X, Lin L, et al. Aberrant methylation of RASSF2A in tumors and plasma of patients with epithelial ovarian cancer[J]. Asian Pac J Cancer Prev, 2014, 15(3):1171-1176.
[6] Zhang X, Ma Y, Wu Y, et al. Aberrant promoter methylation and silencing of RASSF2A gene in cervical cancer[J]. J Obstet Gynaecol Res, 2014, 40(5):1375-1381.
[7] 任芳,王丹波. RASSF2基因甲基化与卵巢透明细胞癌的相关性[J]. 中国医科大学学报,2014,43(11):969-972. REN Fang, WANG Danbo. Investigation on the correlation between hypermethylation of RASSF2 and clear cell ovarian carcinoma[J]. Journal of China Medical University, 2014, 43(11):969-972.
[8] Costello JF, Plass C. Methylation matters[J]. J Med Gent, 2001, 38(5):285-303.
[9] Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation[J]. N Engl J Med, 2003, 349(21):2042-2054.
[10] Akino K, Toyota M, Suzuki H, et al. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer[J]. Gastroenterology, 2005, 129(1):156-169.
[11] Hesson LB, Wilson R, Morton D, et al. CpG island promoter hypermethylation of a novel Ras effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutuation[J]. Oncogene, 2005, 24(24):3987-3994.
[12] Park HW, Kang HC, Kim IJ, et al. Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers[J]. Int J Cancer, 2007,120(1):7-12.
[13] Liao X, Siu MK, Chan KY, et al. Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carciongenesis[J]. Int J Cancer, 2008, 123(2):296-302.
[14] Zhang Z, Sun D, Van do N, et al. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma[J]. Int J Cancer, 2007, 120(1):32-38.
[15] Zhao L, Cui Q, Lu Z, et al. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features[J]. Pancreas, 2012, 41(2):206-211.
[1] ZHAO Jincheng, SHI Ying, ZHANG Ying, JIA Zhanhong, MA Xin, ZHANG Jingqiu, WU Zaijun, WANG Yu. Expression and methylation patterns of CDH13 in human head and neck squamous carcinoma cells. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 60-63.
[2] ZHU Xiaocheng, QIAN Xiaoyun, GU Yajun, SHEN Xiaohui, SONG Panpan, LI Hui, GAO Xia. Expression and clinical value of MGMT and EGFR in laryngeal squamous cell carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 68-72.
[3] LIU Fang1, LAI Jian-xin1, LI Rui-yu1, LI Guan-zhen2. Th17/Treg cell ratio in the peripheral circμlation of human laryngeal squamous cell carcinoma. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 4-7.
[4] XU Hai-yan1, PENG Jie-ren1, OU Yong-kang1, ZHANG Qiong-xia2, ZHANG Cun-liang1, TANG Zhi-ping1, GUAN Zhong1. Expression and clinicopathological significance of nuclear epidermal growth factor receptor, Aurora-A kinase in laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(5): 16-21.
[5] WU Gui-qing1, TIAN Jun2, SUN Jing1, CHEN Qi1. 1. Expression and significance of Tiam1 and MTA1in human laryngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(1): 41-43.
[6] . Expression of the KAI1 gene in laryngeal carcinoma and metastasis lymph nodes [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(2): 11-13.
[7] XU Zhi-jian ,PENG Jie-ren,HUANG Xiao-ming,GUAN Zhong,ZHU Xiao-fen,LIAO Yan-ping . Expression of the Ras-GTPase-activiting protein SH 3 domain binding protein
in laryngeal squamous cell carcinoma and it clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2008, 22(5): 401-404 .
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd